The device will offer temporary relief of sinus pain by harnessing the body’s natural electrical system.
The tip of the device is applied only to the outside of the sinuses. The device is non-invasive, it does not use any pharmaceuticals and can be used anytime and anywhere, the company said.
By showcasing this product, Tivic Health Systems is actively reaching out to medical and investor communities in preparation for the launch of SYNUS Pain Relief later this year.
As per the Center for Disease Control’s (CDC), National Health Interview Survey 2015, about 30 million US adults are diagnosed with sinusitis.
Tivic Health’s SYNUS Pain Relief is claimed to provide relief by using microcurrent waveforms at very low current levels to target sinus pain, pressure and congestion.
This new treatment approach is claimed to target the sinus passages directly by stimulating the sinus nerve pathways.
Tivic Health Systems was started in 2016 by CEO Jennifer Ernst and inventor John Claude, an experienced biomedical engineer. The two collaborated to form the company to commercialize SYNUS.
Ernst said: “I saw an untapped opportunity to help millions suffering from frequent sinus issues. Our research told us that over 70% of sinus sufferers receive little to no relief from existing products, and only 8% are fully satisfied with their current treatment regimen.”
At the Future Healthcare Event, Ernst along with the Tivic Health Systems’ research and scientific affairs vice president Blake Gurfein will be participating.
Gurfein said: “My work has focused on non-invasive neuromodulation. It’s exciting to join a team that’s leveraging the potential healing properties of microcurrent neuromodulation.
“Presently, we are conducting a clinical trial for submission to the FDA.”
Image: Tivic Health previews SYNUS Pain Relief device to healthcare professionals at Future Healthcare Event 2018. Photo: Courtesy of Business Wire.
